Briefs: Medicamen Biotech, Aurobindo Pharma and Ajooni Biotech
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Subscribe To Our Newsletter & Stay Updated